Brazilian Health Biotechnology Innovation System: an essay about the public policy rationale

Authors

  • Carlos Bianchi Universidad de la Republica Uruguay, UDELAR, Uruguai

DOI:

https://doi.org/10.21664/2238-8869.2016v5i1.p14-30

Abstract

The emergence of biotechnology is one of the most important changes in the health innovation systems. This paper discusses the rationale that has supported the public policies oriented to boost health biotechnology development in Brazil during 2004 and 2014. Based on a thorough revision of policy documents and on an extensive fieldwork, the study highlights the accumulative path followed by the Brazilian public policies. This research shows how these policies followed an uneven accumulative path were several rationales cohabited integrating explicit and implicit policies. Finally, the boundaries of policy action are discussed, stressing two critical dimensions that delimit the scope of policy action: i) the change of policy orientation and rationale, ii) that pose new governance’s challenges, which, in turn require new coordination with other implicit policies.

Author Biography

Carlos Bianchi, Universidad de la Republica Uruguay, UDELAR, Uruguai

Doutor em Economia da Indústria e da Tecnologia pela Universidade Federal do Rio de Janeiro, UFRJ. Docente na Universidad de la Republica Uruguay, UDELAR, Uruguai.

Published

2016-06-28

How to Cite

BIANCHI, Carlos. Brazilian Health Biotechnology Innovation System: an essay about the public policy rationale. Fronteiras - Journal of Social, Technological and Environmental Science, [S. l.], v. 5, n. 1, p. 14–30, 2016. DOI: 10.21664/2238-8869.2016v5i1.p14-30. Disponível em: https://revistas.unievangelica.edu.br/index.php/fronteiras/article/view/1619. Acesso em: 22 nov. 2024.

Issue

Section

Dossier –Biotechnology and Innovation: from Research and Teaching Laboratories to Public Politics